Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature

Rubina A. Heptulla, Susan D. Boulware, Sonia Caprio, David Silver, Robert S. Sherwin, William V. Tamborlane

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

To assess the effects of GH treatment on carbohydrate and protein metabolism, we studied eight patients with short stature before and after the commencement of GH treatment. The hyperglycemic clamp procedure was employed to produce a hyperglycemic stimulus of 50 mg/dL above fasting levels for 120 min. These patients were then treated with 0.3 mg/kg · week GH for 6 months, after which they were restudied. Patients were compared to eight healthy control children matched for age, sex, and Tanner stage. Fasting plasma glucose did not change significantly, but fasting plasma insulin levels were higher after GH therapy (P < 0.005). Despite identical glucose increments during the glucose clamp procedure, both first and second phase insulin responses were markedly greater after instituting GH treatment. Even in the face of higher mean plasma insulin levels after GH treatment, the rate of insulin-stimulated glucose metabolism did not differ during the last 60 min of both studies. Hence, the rate of insulin-stimulated glucose metabolism/mean plasma insulin ratio (an index of insulin sensitivity) was sharply reduced after GH treatment (P < 0.01). During the clamp, the fall in circulating branched chain amino acid levels was significantly greater after GH therapy (P < 0.02). We conclude that glucose-stimulated insulin responses are increased in short children treated with GH and that such hyperinsulinemic responses compensate for reductions in insulin sensitivity. The compensatory hyperinsulinemic responses induced by GH therapy may serve a beneficial role by augmenting insulin's anabolic effects on protein metabolism.

Original languageEnglish (US)
Pages (from-to)3234-3238
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume82
Issue number10
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Hyperinsulinism
Insulin Resistance
Hormones
Insulin
Metabolism
Glucose
Clamping devices
Fasting
Plasmas
Therapeutics
Anabolic Agents
Branched Chain Amino Acids
Glucose Clamp Technique
Carbohydrate Metabolism
Proteins
Carbohydrates

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature. / Heptulla, Rubina A.; Boulware, Susan D.; Caprio, Sonia; Silver, David; Sherwin, Robert S.; Tamborlane, William V.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 82, No. 10, 1997, p. 3234-3238.

Research output: Contribution to journalArticle

Heptulla, Rubina A. ; Boulware, Susan D. ; Caprio, Sonia ; Silver, David ; Sherwin, Robert S. ; Tamborlane, William V. / Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature. In: Journal of Clinical Endocrinology and Metabolism. 1997 ; Vol. 82, No. 10. pp. 3234-3238.
@article{8897916a138641348ff61b8d2daa221b,
title = "Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature",
abstract = "To assess the effects of GH treatment on carbohydrate and protein metabolism, we studied eight patients with short stature before and after the commencement of GH treatment. The hyperglycemic clamp procedure was employed to produce a hyperglycemic stimulus of 50 mg/dL above fasting levels for 120 min. These patients were then treated with 0.3 mg/kg · week GH for 6 months, after which they were restudied. Patients were compared to eight healthy control children matched for age, sex, and Tanner stage. Fasting plasma glucose did not change significantly, but fasting plasma insulin levels were higher after GH therapy (P < 0.005). Despite identical glucose increments during the glucose clamp procedure, both first and second phase insulin responses were markedly greater after instituting GH treatment. Even in the face of higher mean plasma insulin levels after GH treatment, the rate of insulin-stimulated glucose metabolism did not differ during the last 60 min of both studies. Hence, the rate of insulin-stimulated glucose metabolism/mean plasma insulin ratio (an index of insulin sensitivity) was sharply reduced after GH treatment (P < 0.01). During the clamp, the fall in circulating branched chain amino acid levels was significantly greater after GH therapy (P < 0.02). We conclude that glucose-stimulated insulin responses are increased in short children treated with GH and that such hyperinsulinemic responses compensate for reductions in insulin sensitivity. The compensatory hyperinsulinemic responses induced by GH therapy may serve a beneficial role by augmenting insulin's anabolic effects on protein metabolism.",
author = "Heptulla, {Rubina A.} and Boulware, {Susan D.} and Sonia Caprio and David Silver and Sherwin, {Robert S.} and Tamborlane, {William V.}",
year = "1997",
doi = "10.1210/jc.82.10.3234",
language = "English (US)",
volume = "82",
pages = "3234--3238",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature

AU - Heptulla, Rubina A.

AU - Boulware, Susan D.

AU - Caprio, Sonia

AU - Silver, David

AU - Sherwin, Robert S.

AU - Tamborlane, William V.

PY - 1997

Y1 - 1997

N2 - To assess the effects of GH treatment on carbohydrate and protein metabolism, we studied eight patients with short stature before and after the commencement of GH treatment. The hyperglycemic clamp procedure was employed to produce a hyperglycemic stimulus of 50 mg/dL above fasting levels for 120 min. These patients were then treated with 0.3 mg/kg · week GH for 6 months, after which they were restudied. Patients were compared to eight healthy control children matched for age, sex, and Tanner stage. Fasting plasma glucose did not change significantly, but fasting plasma insulin levels were higher after GH therapy (P < 0.005). Despite identical glucose increments during the glucose clamp procedure, both first and second phase insulin responses were markedly greater after instituting GH treatment. Even in the face of higher mean plasma insulin levels after GH treatment, the rate of insulin-stimulated glucose metabolism did not differ during the last 60 min of both studies. Hence, the rate of insulin-stimulated glucose metabolism/mean plasma insulin ratio (an index of insulin sensitivity) was sharply reduced after GH treatment (P < 0.01). During the clamp, the fall in circulating branched chain amino acid levels was significantly greater after GH therapy (P < 0.02). We conclude that glucose-stimulated insulin responses are increased in short children treated with GH and that such hyperinsulinemic responses compensate for reductions in insulin sensitivity. The compensatory hyperinsulinemic responses induced by GH therapy may serve a beneficial role by augmenting insulin's anabolic effects on protein metabolism.

AB - To assess the effects of GH treatment on carbohydrate and protein metabolism, we studied eight patients with short stature before and after the commencement of GH treatment. The hyperglycemic clamp procedure was employed to produce a hyperglycemic stimulus of 50 mg/dL above fasting levels for 120 min. These patients were then treated with 0.3 mg/kg · week GH for 6 months, after which they were restudied. Patients were compared to eight healthy control children matched for age, sex, and Tanner stage. Fasting plasma glucose did not change significantly, but fasting plasma insulin levels were higher after GH therapy (P < 0.005). Despite identical glucose increments during the glucose clamp procedure, both first and second phase insulin responses were markedly greater after instituting GH treatment. Even in the face of higher mean plasma insulin levels after GH treatment, the rate of insulin-stimulated glucose metabolism did not differ during the last 60 min of both studies. Hence, the rate of insulin-stimulated glucose metabolism/mean plasma insulin ratio (an index of insulin sensitivity) was sharply reduced after GH treatment (P < 0.01). During the clamp, the fall in circulating branched chain amino acid levels was significantly greater after GH therapy (P < 0.02). We conclude that glucose-stimulated insulin responses are increased in short children treated with GH and that such hyperinsulinemic responses compensate for reductions in insulin sensitivity. The compensatory hyperinsulinemic responses induced by GH therapy may serve a beneficial role by augmenting insulin's anabolic effects on protein metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0030883877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030883877&partnerID=8YFLogxK

U2 - 10.1210/jc.82.10.3234

DO - 10.1210/jc.82.10.3234

M3 - Article

C2 - 9329345

AN - SCOPUS:0030883877

VL - 82

SP - 3234

EP - 3238

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -